Arbutus Biopharma Corporation
ABUS
$5.17
-$0.01-0.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.73% | 4.11% | -2.38% | -4.47% | -12.97% |
| Total Receivables | -0.17% | 10,229.31% | 44.98% | 7.11% | -18.60% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -16.22% | 7.59% | -51.16% | -35.10% | 43.66% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -1.13% | 193.27% | -3.06% | -5.51% | -11.72% |
|
|
|||||
| Total Current Assets | -1.13% | 193.27% | -3.06% | -5.51% | -11.72% |
| Net Property, Plant & Equipment | -54.55% | -31.25% | -76.64% | -7.43% | -11.90% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.76% | 0.77% | -0.76% | -- | -- |
| Total Assets | -1.13% | 192.93% | -3.16% | -5.38% | -11.75% |
|
|
|||||
| Total Accounts Payable | -74.49% | 24.64% | 16.02% | -23.47% | -41.03% |
| Total Accrued Expenses | -16.26% | -24.11% | 26.64% | 19.02% | -38.04% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -18.54% | 15.36% | 3.01% | 3.31% | -8.70% |
| Total Finance Division Other Current Liabilities | -34.69% | -61.72% | -16.12% | -0.65% | -93.96% |
| Total Other Current Liabilities | -34.69% | -61.72% | -16.12% | -0.65% | -93.96% |
| Total Current Liabilities | -34.10% | -15.00% | 15.86% | 3.23% | -74.15% |
|
|
|||||
| Total Current Liabilities | -34.10% | -15.00% | 15.86% | 3.23% | -74.15% |
| Long-Term Debt | -5.09% | -4.76% | -6.57% | -5.78% | -11.32% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -49.10% | -32.00% | -8.15% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.48% | 2.49% | -24.04% | 2.49% | -19.44% |
| Total Liabilities | -9.98% | -5.85% | -11.17% | 0.10% | -46.40% |
|
|
|||||
| Common Stock & APIC | 0.25% | 0.93% | 0.19% | 0.14% | 0.09% |
| Retained Earnings | -0.42% | 12.30% | -0.27% | -0.57% | 0.18% |
| Treasury Stock & Other | -0.10% | -0.20% | 0.06% | 0.12% | -0.04% |
| Total Common Equity | -0.56% | 239.76% | -1.06% | -6.72% | 4.82% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -0.56% | 239.76% | -1.06% | -6.72% | 4.82% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -0.56% | 239.76% | -1.06% | -6.72% | 4.82% |
|
|
|||||